LABT

distress 8/10 · high distress / dilution risk

$3.400%today-96% from 52w high

lakewoodamedex.com5 employeesFounded 2006University Park, FLBiotechnology

Revenue

pre-revenue

Liquidity

$0M

Runway

0.0 yrs

Shares 1y

—

Price & events

-96.1% over 6M

CatalystRating changeDilutionFinancingdashed = today

-0.3%

+83.8%

-14.4%

-96.1%

—

-96.1%

All

Overview

Market Cap: $23.78M
Volume: 992.20K
52 Week Range: $1.85 – $86.50
Total Shares: 7.00M
Float Shares: 283.27K
Short %: 6.29%
% Held by Insiders: 48.67%
% Held by Institutions: 0.00%
RVOL: 0.34x

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 6,995,469 · 7 offerings/1y · 0 PIPEs

2026-06-22424B3offering
2026-06-22424B3offering
2026-05-26424B3offering
2026-05-26424B3offering
2026-05-14424B4offering
2026-05-13EFFECTshelf_effective
2026-05-01S-1shelf_registration

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

strong buy · target $12 (+253% upside) · 1 analysts

no recent rating changes

Competitors

none identified